Prevalence of FGIDs and Probiotics Study

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Functional Gastrointestinal Disorders, Infant Conditions

In brief

This is a study to evaluate the prevalence of FGIDs in infants using the Thai version of Rome IV diagnostic questionnaire for functional gastrointestinal disorders in infants and evaluate the efficacy of Limosilactobacillus reuteri DSM 17938 to prevent FGIDs in infants.

Key facts

Study ID

NCT06309199

Run by

Chulalongkorn University

People needed

512

Starts

2024-03-14

Expected to finish

2026-02-01

Last updated by the study team

2025-07-02

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy and term (GA 37-41 weeks) infants
• Appropriate weight for age
• APGAR score more than 8 at 10 minutes of life
• Normal physical examination
• Mothers have no previous probiotics use

You may not qualify if…

• not willing to anticipate in the study
• cannot come to follow-up until 1 year of age

Where it is running

• Maha Chakri Sirindhorn Clinical Research Center (Chula CRC) — Bangkok, Bangkok, Thailand (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.